Overview

Detailed Summary

Medicamen Organics Limited specializes in developing, manufacturing, and distributing a diverse range of pharmaceutical products including tablets, capsules, syrups, and dry powders.
The company is strategically focused on global expansion, notably entering the Nepalese market through a partnership with Medi Hub Organic Limited, complemented by a new subsidiary, Grande Etoile Pharmaceuticals.
Medicamen witnessed a substantial 51% increase in revenue year-on-year and a 54% rise in PAT, driven by its strategic initiatives and operational efficiencies.
The company is capitalizing on consumer trends in the global beauty market with its new endeavor into cruelty-free cosmetics and skincare, aiming for a significant share in the $700 billion market.
Medicamen recently issued 4,65,910 convertible warrants on a preferential basis to the Promoter Group to raise INR3 crores, strengthening its working capital for further growth.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 26 Cr
Volatility: Low Risk
P/E Ratio: -6.5
Industry P/E: 34.1
PEG Ratio: —
P/B Ratio: 0.9
52W High: 49.70
52W Low: 19.10

Sales CAGR

1Y: 51.13%
3Y: 20.92%
5Y: 3.33%
10Y: —

Profit CAGR

1Y: 54.58%
3Y: 228.46%
5Y: 99.94%
10Y: —

ROE

TTM: -13.99%
3Y: 12.72%
5Y: 10.52%
10Y: —

ROCE

TTM: -10.62%
3Y: 20.33%
5Y: 17.60%
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GUJTERC		34.50	27 Cr	12.11	2.76	0.00	25.62	29.29	9.04
MEDIORG		20.50	25 Cr	-6.20	0.87	0.00	-13.99	-10.62	-7.79
PARMAX		65.39	24 Cr	-5.89	0.00	0.00	67.65	-85.76	-14.80
VENMAX		20.35	24 Cr	122.15	1.73	0.00	1.76	1.92	1.23
VINRKLB		37.46	23 Cr	-90.32	0.00	0.00	20.74	-104.17	-21.01
WALPAR		24.05	23 Cr	9.14	1.19	0.00	13.09	13.74	4.84
ISHITADR		73.75	22 Cr	28.27	1.91	0.00	6.73	9.78	6.19
Median: 7 Co.	—	34.50	24 Cr	9.14	1.19	0.00	13.09	1.92	1.23

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Half Yearly Results (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	14	17	22	18	4.78
Expenses	12	14	18	14	12
Interest	0.36	0.22	0.29	0.33	0.38
Operating Profit	2.33	2.73	3.85	3.42	-7.18
OPM %	16.70	16.44	17.84	19.16	-150.21
Other Income	0.01	0.04	0.05	0.06	0.02
Depreciation	0.36	0.36	0.37	0.41	0.48
Profit Before Tax	1.62	2.19	3.24	2.74	-8.02
Tax %	22.22	31.05	21.91	25.55	24.44
Net Profit	1.26	1.51	2.54	2.04	-6.06
EPS in Rs	—	—	—	—	—

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025
Sales	25	38
Expenses	21	32
Operating Profit	4.74	6.59
OPM %	18.75	17.25
Other Income	0.02	0.10
Interest	0.65	0.51
Depreciation	0.72	0.74
Profit Before Tax	4.44	5.43
Tax %	40.85	25.47
Net Profit	2.62	4.05
EPS in Rs	—	—
Dividend Payout %	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025
Equity Capital	8.60	12
Reserves	6.66	18
Borrowings	13	12
Other Liabilities	11	17
Total Liabilities	38	59
Fixed Assets	10	10
CWIP	0.15	2.22
Investments	0.00	0.00
Other Assets	28	47
Total Assets	38	59

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2024	Mar 2025
Cash from Operating Activity	-3.66	-4.54
Cash from Investing Activity	-0.34	-2.35
Cash from Financing Activity	4.01	10
Net Cash Flow	0.01	3.58

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Feb 2024	Jun 2024	Sep 2024	Mar 2025	Sep 2025	Jan 2026	Mar 2026
Promoters	81.21%	59.69%	59.69%	59.73%	59.73%	61.27%	59.73%
FIIs	0.00%	2.22%	0.14%	0.07%	0.00%	0.07%	0.07%
DIIs	18.79%	5.30%	3.76%	3.79%	3.76%	3.55%	1.64%
Public	0.00%	32.79%	36.41%	36.41%	36.51%	35.12%	38.56%
Total Shareholders	34	472	379	460	507	515	540

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q2 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Medicamen Organics Ltd

Medicamen Organics Ltd (MEDIORG) is currently trading at 21.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Medicamen Organics Limited specializes in developing, manufacturing, and distributing a diverse range of pharmaceutical products including tablets, capsules, syrups, and dry powders. The company is strategically focused on global expansion, notably entering the Nepalese market through a partnership with Medi Hub Organic Limited, complemented by a new subsidiary, Grande Etoile Pharmaceuticals. Medicamen witnessed a substantial 51% increase in revenue year-on-year and a 54% rise in PAT, driven by its strategic initiatives and operational efficiencies. The company is capitalizing on consumer trends in the global beauty market with its new endeavor into cruelty-free cosmetics and skincare, aiming for a significant share in the $700 billion market. Medicamen recently issued 4,65,910 convertible warrants on a preferential basis to the Promoter Group to raise INR3 crores, strengthening its working capital for further growth.

Over the past 52 weeks, Medicamen Organics Ltd has traded between a low of ₹19.10 and a high of ₹49.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Medicamen Organics Ltd has a market capitalization of approximately 24.94. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Medicamen Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -6.20 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 24.94 Cr, Medicamen Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Medicamen Organics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Medicamen Organics Ltd is -6.20. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Medicamen Organics Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Half Yearly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Medicamen Organics Ltd

What is Medicamen Organics Ltd share price today?

What does Medicamen Organics Ltd do?

What is the 52-week high and low of Medicamen Organics Ltd?

What is the market capitalization of Medicamen Organics Ltd?

Should I consider investing in Medicamen Organics Ltd stock?

Is Medicamen Organics Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Medicamen Organics Ltd belong to and why does it matter?

What is the PE ratio of Medicamen Organics Ltd?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Frequently Asked Questions about Medicamen Organics Ltd

What is Medicamen Organics Ltd share price today?

What does Medicamen Organics Ltd do?

What is the 52-week high and low of Medicamen Organics Ltd?

What is the market capitalization of Medicamen Organics Ltd?

Should I consider investing in Medicamen Organics Ltd stock?

Is Medicamen Organics Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Medicamen Organics Ltd belong to and why does it matter?

What is the PE ratio of Medicamen Organics Ltd?

Announcements

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist